Literature DB >> 12551998

A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites.

Cheng-Wen Lin1, Suh-Chin Wu.   

Abstract

The envelope (E) protein of Japanese encephalitis virus (JEV) is associated with viral binding to cellular receptors, membrane fusion, and the induction of protective neutralizing-antibody responses in hosts. Most previous studies have not provided detailed molecular information about the spatial configuration of the functional epitopes on domain III of the E protein. Here site-directed mutagenesis was performed to demonstrate that the functional epitope determinants at Ser331 and Asp332 on domain III of the JEV E protein interacted with neutralizing monoclonal antibody (MAb) E3.3. Bacterial expression of the recombinant Fab E3.3 confirmed the molecular interactions of Arg94 in complementary determining region H3 with Ser331 and Asp332 on domain III. This study elucidates the detailed molecular structures of the neutralizing epitope determinants on JEV domain III, which can provide useful information for designing new vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12551998      PMCID: PMC141121          DOI: 10.1128/jvi.77.4.2600-2606.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Characterization of neutralizing anti-pre-S1 and anti-pre-S2 (HBV) monoclonal antibodies and their fragments.

Authors:  G Küttner; A Kramer; G Schmidtke; E Giessmann; L Dong; D Roggenbuck; C Scholz; M Seifert; R D Stigler; J Schneider-Mergener; T Porstmann; W Höhne
Journal:  Mol Immunol       Date:  1999-07       Impact factor: 4.407

2.  Binding of an antibody mimetic of the human low density lipoprotein receptor to apolipoprotein E is governed through electrostatic forces. Studies using site-directed mutagenesis and molecular modeling.

Authors:  R Raffaï; K H Weisgraber; R MacKenzie; B Rupp; E Rassart; T Hirama; T L Innerarity; R Milne
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

3.  Site-specific mutagenesis of a recombinant anti-single-stranded DNA Fab. Role of heavy chain complementarity-determining region 3 residues in antigen interaction.

Authors:  A A Komissarov; M T Marchbank; M J Calcutt; T P Quinn; S L Deutscher
Journal:  J Biol Chem       Date:  1997-10-24       Impact factor: 5.157

4.  Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.

Authors:  J T Roehrig; R A Bolin; R G Kelly
Journal:  Virology       Date:  1998-07-05       Impact factor: 3.616

5.  The atomic structure of protein-protein recognition sites.

Authors:  L Lo Conte; C Chothia; J Janin
Journal:  J Mol Biol       Date:  1999-02-05       Impact factor: 5.469

6.  Conformations of the third hypervariable region in the VH domain of immunoglobulins.

Authors:  V Morea; A Tramontano; M Rustici; C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1998-01-16       Impact factor: 5.469

7.  Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.

Authors:  K Hiramatsu; M Tadano; R Men; C J Lai
Journal:  Virology       Date:  1996-10-15       Impact factor: 3.616

8.  Secondary structure of the 3'-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities.

Authors:  S Rauscher; C Flamm; C W Mandl; F X Heinz; P F Stadler
Journal:  RNA       Date:  1997-07       Impact factor: 4.942

9.  Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence.

Authors:  S C Wu; W C Lian; L C Hsu; M Y Liau
Journal:  Virus Res       Date:  1997-10       Impact factor: 3.303

10.  Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain.

Authors:  J J Schlesinger; S Chapman; A Nestorowicz; C M Rice; T E Ginocchio; T J Chambers
Journal:  J Gen Virol       Date:  1996-06       Impact factor: 3.891

View more
  37 in total

1.  Expression of domain III of the envelope protein from GP-78: a Japanese encephalitis virus.

Authors:  Sahil Kulkarni; Sandeepan Mukherjee; Krishna Mohan Padmanabha Das; Kaushiki Prabhudesai; Nupur Deshpande; Sushant Karnik; Abhay S Chowdhary; Usha Padmanabhan
Journal:  Virusdisease       Date:  2017-05-25

2.  Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein.

Authors:  John T Roehrig; Katharine E Volpe; Jennifer Squires; Ann R Hunt; Brent S Davis; Gwong-Jen J Chang
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Histidine at residue 99 and the transmembrane region of the precursor membrane prM protein are important for the prM-E heterodimeric complex formation of Japanese encephalitis virus.

Authors:  Ying-Ju Lin; Suh-Chin Wu
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.

Authors:  Tetsuya Harakuni; Hideki Sugawa; Ai Komesu; Masayuki Tadano; Takeshi Arakawa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  NMR solution structure and backbone dynamics of domain III of the E protein of tick-borne Langat flavivirus suggests a potential site for molecular recognition.

Authors:  Munia Mukherjee; Kaushik Dutta; Mark A White; David Cowburn; Robert O Fox
Journal:  Protein Sci       Date:  2006-06       Impact factor: 6.725

Review 6.  Closing the door on flaviviruses: entry as a target for antiviral drug design.

Authors:  Rushika Perera; Mansoora Khaliq; Richard J Kuhn
Journal:  Antiviral Res       Date:  2008-06-11       Impact factor: 5.970

7.  The envelope glycoprotein domain III of Dengue virus type 2 induced the expression of anticoagulant molecules in endothelial cells.

Authors:  Lien-Cheng Chen; Trai-Ming Yeh; Yi-Ying Lin; Yi-Fen Wang; Shu-Jem Su; Chang-Yu Chen; Kuan-Hua Lin; Miao-Chen Chou; Huey-Wen Shyu
Journal:  Mol Cell Biochem       Date:  2010-06-05       Impact factor: 3.396

8.  Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.

Authors:  Ruhe Men; Tetsu Yamashiro; Ana P Goncalvez; Claire Wernly; Darren J Schofield; Suzanne U Emerson; Robert H Purcell; Ching-Juh Lai
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Characterization of the GXXXG motif in the first transmembrane segment of Japanese encephalitis virus precursor membrane (prM) protein.

Authors:  Ying-Ju Lin; Jia-Guan Peng; Suh-Chin Wu
Journal:  J Biomed Sci       Date:  2010-05-24       Impact factor: 8.410

10.  An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.

Authors:  Jan-Jong Hung; Meng-Ti Hsieh; Ming-Jer Young; Chuan-Liang Kao; Chwan-Chuen King; Wen Chang
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.